Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Examining modifiable risk factors previously associated with breast cancer incidence on breast cancer survival among BRCA mutation carriers
EF 2019-20
Résumé
Those who inherit a deleterious BRCA mutation face a high lifetime risk of developing breast cancer compared to the general population. Modifiable risk factors such as physical activity, BMI, and dietary intake have previously been shown to increase or decrease the risk of developing breast cancer in BRCA mutation carriers; however, the effect of these modifiable risk factors have not been examined in survival after the diagnosis of breast cancer in this population. BRCA mutation carriers are typically associated with worse overall survival outcomes following the diagnosis of a breast cancer, compared to the general population. Since there is a role for modifiable risk factors in modifying breast cancer risk among BRCA mutation carriers, I hypothesize that these modifiable risk factors will also have a role in breast cancer survival after diagnosis of a breast cancer. Therefore the objectives of this study are to evaluate if the following modifiable risk factors impact breast cancer survival among BRCA mutation carriers:
1) energy balance (physical activity and BMI)
2) dietary intake (circulating vitamin D, folate, iron, and selenium levels)
3) lifestyle factors (smoking and alcohol).
To our knowledge, this study will be the first to evaluate the effect of various lifestyle and dietary factors on breast cancer survival among BRCA mutation carriers. These findings will have the potential to compliment current treatment options, reduce breast cancer death attributed to a BRCA1/2 mutation, and ultimately help improve outcomes among those who develop the disease.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
417012
Name
Kim Shana J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
Examining modifiable risk factors previously associated with breast cancer incidence on breast cancer survival among BRCA mutation carriers
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Brca; Breast Cancer; Breast Cancer Survival; Diet And Lifestyle; Epidemiology; Nutrition; Nutritional Epidemiology
Abstract
Those who inherit a deleterious BRCA mutation face a high lifetime risk of developing breast cancer compared to the general population. Modifiable risk factors such as physical activity, BMI, and dietary intake have previously been shown to increase or decrease the risk of developing breast cancer in BRCA mutation carriers; however, the effect of these modifiable risk factors have not been examined in survival after the diagnosis of breast cancer in this population. BRCA mutation carriers are typically associated with worse overall survival outcomes following the diagnosis of a breast cancer, compared to the general population. Since there is a role for modifiable risk factors in modifying breast cancer risk among BRCA mutation carriers, I hypothesize that these modifiable risk factors will also have a role in breast cancer survival after diagnosis of a breast cancer. Therefore the objectives of this study are to evaluate if the following modifiable risk factors impact breast cancer survival among BRCA mutation carriers:
1) energy balance (physical activity and BMI)
2) dietary intake (circulating vitamin D, folate, iron, and selenium levels)
3) lifestyle factors (smoking and alcohol).
To our knowledge, this study will be the first to evaluate the effect of various lifestyle and dietary factors on breast cancer survival among BRCA mutation carriers. These findings will have the potential to compliment current treatment options, reduce breast cancer death attributed to a BRCA1/2 mutation, and ultimately help improve outcomes among those who develop the disease.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kim, Shana J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~